Den 14. februar 2007 vedtoges en kombineret fornyelse, via den gensidige anerkendelsesprocedure, for Remeron filmovertrukne tabletter, 45 mg, Remeron, 15, 30, 45 mg, Remeron oral opløsning 15 mg/ ml, Mirtazapin smeltetabletter, 15, 30, 45 mg, som omfattede i alt otte medlemsstater, herunder referencemedlemsstaten (RMS).
On 14 February 2007 a combined renewal via MRP was concluded for Remeron film-coated tablets 45 mg, Remeron 15, 30, 45 mg, Remeron oral solution 15 mg/ ml, Mirtazapine orodispersible tablets 15, 30, 45 mg., involving in total 8 Member States, including the Reference Member State (RMS).